Search

Author/Creator Levin, C.

1. Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small‐platelet thrombocytopenia. (25th May 2015)

Authors:
Levin, C.; Koren, A.; Pretorius, E.; Rosenberg, N.; Shenkman, B.; Hauschner, H.; Zalman, L.; Khayat, M.; Salama, I.; Elpeleg, O.; Shalev, S.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 13:Number 7(2015:Jul.)
Page Start:
1285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small‐platelet thrombocytopenia. (25th May 2015)

Authors:
Levin, C.; Koren, A.; Pretorius, E.; Rosenberg, N.; Shenkman, B.; Hauschner, H.; Zalman, L.; Khayat, M.; Salama, I.; Elpeleg, O.; Shalev, S.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 13:Number 7(2015:Jul.)
Page Start:
1285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P817: SYNDROMES PREDISPOSING TO LEUKEMIA ARE A MAJOR CAUSE OF INHERITED CYTOPENIAS IN CHILDREN. (23rd June 2022)

Authors:
Gilad, O.; Dgany, O.; Noy -Lotan, S.; Krasnov, T.; Yacobovich, J.; Rabinowicz, R.; Goldberg, T.; Kuperman, A.; Abu-Quider, A.; Miskin, H.; Kapelushnik, N.; Mandel-Shorer, N.; Shimony, S.; Harlev, D.; Ben-Ami, T.; Adam, E.; Levin, C.; Aviner, S.; Elhasid, R.; Berger-Achituv, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
711
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P835: GENETIC BACKGROUND AND CLINICAL CHARACTERISTICS OF CONGENITAL NEUTROPENIAS IN ISRAEL. (23rd June 2022)

Authors:
Steinberg-Shemer, O.; Yeshareem, L.; Noy-Lotan, S.; Dgany, O.; Krasnov, T.; Berger Pinto, G.; Bielorai, B.; Kuperman, A. A.; Laor, R.; Mandel-Shorer, N.; Ben Barak, A.; Levin, C.; Mahdi, A.; Miskin, H.; Revel-Vilk, S.; Levin, D.; Benish, M.; Zuckerman, T.; Wolach, O.; Pazgal, I.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
729
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. PB1938: 4WHIM: EVALUATING MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH WHIM SYNDROME VIA A GLOBAL PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION. (23rd June 2022)

Authors:
Dale, D. C.; Alsina, L.; Azar, A.; Badolato, R.; Bertrand, Y.; Deya, A.; Dickerson, K. E.; Ezra, N.; Hasle, H.; Kang, H. J.; Kiani-Alikhan, S.; Kuijpers, T.; Kulagin, A.; Langguth, D.; Levin, C.; Neth, O.; Peake, J.; Rutten, C. E.; Shcherbina, A.; Tarrant, T. K.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1814
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗